These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2439533)

  • 1. Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32).
    Webster HK; Boudreau EF; Pang LW; Permpanich B; Sookto P; Wirtz RA
    J Clin Microbiol; 1987 Jun; 25(6):1002-8. PubMed ID: 2439533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
    N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antibody responses to the circumsporozoite protein repeat region and to intact sporozoites during acute falciparum malaria.
    Brown AE; Webster HK; Pavanand K; Permpanich B; Sookto P; Sattabongkot J; Gingrich JB
    Trans R Soc Trop Med Hyg; 1989; 83(2):154-7. PubMed ID: 2692219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte responsiveness to a candidate malaria sporozoite vaccine (R32tet32) of individuals with naturally acquired Plasmodium falciparum malaria.
    Webster HK; Ho M; Looareesuwan S; Pavanand K; Wattanagoon Y; Warrell DA; Hockmeyer WT
    Am J Trop Med Hyg; 1988 Jan; 38(1):37-41. PubMed ID: 3277463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection.
    Webster HK; Brown AE; Chuenchitra C; Permpanich B; Pipithkul J
    J Clin Microbiol; 1988 May; 26(5):923-7. PubMed ID: 2454941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum: sporozoite boosting of immunity due to a T-cell epitope on a sporozoite vaccine.
    Hoffman SL; Cannon LT; Berzofsky JA; Majarian WR; Young JF; Maloy WL; Hockmeyer WT
    Exp Parasitol; 1987 Aug; 64(1):64-70. PubMed ID: 2440712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides.
    Del Giudice G; Verdini AS; Pinori M; Pessi A; Verhave JP; Tougne C; Ivanoff B; Lambert PH; Engers HD
    J Clin Microbiol; 1987 Jan; 25(1):91-6. PubMed ID: 2432083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response of humans to the circumsporozoite protein of Plasmodium falciparum: limited T cell response to the immunodominant central repeat region.
    Campbell JR; Paleologo FP; Franke ED; Ratiwayanto S; Hadiputranto H; Kurniawan L; Wistar R; Hoffman SL; Annis BA; Wasserman G
    Am J Trop Med Hyg; 1988 Sep; 39(3):232-5. PubMed ID: 2459979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malaria.
    Sherwood JA; Oster CN; Adoyo-Adoyo M; Beier JC; Gachihi GS; Nyakundi PM; Ballou WR; Brandling-Bennett AD; Schwartz IK; Were JB
    Trans R Soc Trop Med Hyg; 1991; 85(3):336-40. PubMed ID: 1949134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.
    Del Giudice G; Engers HD; Tougne C; Biro SS; Weiss N; Verdini AS; Pessi A; Degremont AA; Freyvogel TA; Lambert PH
    Am J Trop Med Hyg; 1987 Mar; 36(2):203-12. PubMed ID: 2435181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro.
    Kabilan L; Troye-Blomberg M; Patarroyo ME; Björkman A; Perlmann P
    Clin Exp Immunol; 1987 May; 68(2):288-97. PubMed ID: 3308213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low CD8+ T lymphocyte response to P. falciparum circumsporozoite protein in naturally-exposed malaria endemic populations in Thailand.
    Khusmith S; Tangteerawatana P; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):405-11. PubMed ID: 10774643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
    Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides.
    Del Giudice G; Biro S; Degrémont AA; Engers HD; Lambert PH; Pessi A; Tougne C; Verdini AS; Weiss N; Tanner M
    Parassitologia; 1986; 28(2-3):107-11. PubMed ID: 3332303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: administration of anti-sporozoite antibodies during sporogony results in production of sporozoites which are not neutralized by human anti-circumsporozoite protein vaccine sera.
    do Rosario VE; Appiah A; Vaughan JA; Hollingdale MR
    Trans R Soc Trop Med Hyg; 1989; 83(3):305-7. PubMed ID: 2694460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a sporozoite malaria vaccine.
    Nussenzweig V; Nussenzweig RS
    Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Malaysian sera with Plasmodium vivax sporozoite antigen.
    Lee M; Davis DR; Ballou WR; Folena-Wasserman G; Lewis GE
    Am J Trop Med Hyg; 1988 Dec; 39(6):535-9. PubMed ID: 3061309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.